Literature DB >> 23776296

Cytotoxicity of cyclometallated ruthenium complexes: the role of ligand exchange on the activity.

Alycia M Palmer1, Bruno Peña, R Bryan Sears, Olivia Chen, Maya El Ojaimi, Randolph P Thummel, Kim R Dunbar, Claudia Turro.   

Abstract

The cyclometallated Ru(II) complexes cis-[Ru(phpy)(phen)(CH3CN)2](PF6) (1; phpy(-)=deprotonated 2-phenylpyridine, phen=1,10-phenanthroline) and cis-[Ru(phpy)(bpy)(CH3CN)2](PF6) (2; bpy=2,2'-bipyridine) were investigated as potential agents for photodynamic therapy. The presence of phpy(-) in the coordination sphere results in a red-shift of the Ru→phen and Ru→bpy metal-to-ligand charge transfer of 1 and 2, respectively, thus improving the tissue penetration of light while maintaining the efficient photo-induced ligand exchange required for DNA binding. The 14-fold enhancement of OVCAR-5 cell death that occurs upon irradiation with 690 nm light can be attributed to photo-aquation. The role of glutathione (GSH) on the toxicity of the complex was also explored. Complexes 1 and 2 undergo ligand substitution in the presence of GSH in the dark, such that the metal may covalently bind to biomolecules. The combination of photo-induced ligand exchange and GSH-facilitated ligand exchange may explain the observed cytotoxicity.

Entities:  

Keywords:  glutathione; ligand exchange; photochemistry; photodynamic therapy; ruthenium

Mesh:

Substances:

Year:  2013        PMID: 23776296     DOI: 10.1098/rsta.2012.0135

Source DB:  PubMed          Journal:  Philos Trans A Math Phys Eng Sci        ISSN: 1364-503X            Impact factor:   4.226


  9 in total

1.  Control and utilization of ruthenium and rhodium metal complex excited states for photoactivated cancer therapy.

Authors:  Jessica D Knoll; Claudia Turro
Journal:  Coord Chem Rev       Date:  2015-01-01       Impact factor: 22.315

Review 2.  The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials.

Authors:  Leli Zeng; Pranav Gupta; Yanglu Chen; Enju Wang; Liangnian Ji; Hui Chao; Zhe-Sheng Chen
Journal:  Chem Soc Rev       Date:  2017-10-02       Impact factor: 54.564

Review 3.  Targeting drug delivery with light: A highly focused approach.

Authors:  Teresa L Rapp; Cole A DeForest
Journal:  Adv Drug Deliv Rev       Date:  2021-01-22       Impact factor: 15.470

4.  Combination of Ru(ii) complexes and light: new frontiers in cancer therapy.

Authors:  Cristina Mari; Vanessa Pierroz; Stefano Ferrari; Gilles Gasser
Journal:  Chem Sci       Date:  2015-01-13       Impact factor: 9.825

5.  Kinetics and Photochemistry of Ruthenium Bisbipyridine Diacetonitrile Complexes: An Interdisciplinary Inorganic and Physical Chemistry Laboratory Exercise.

Authors:  Teresa L Rapp; Susan R Phillips; Ivan J Dmochowski
Journal:  J Chem Educ       Date:  2016-11-10       Impact factor: 2.979

6.  In-Cell Activation of Organo-Osmium(II) Anticancer Complexes.

Authors:  Russell J Needham; Carlos Sanchez-Cano; Xin Zhang; Isolda Romero-Canelón; Abraha Habtemariam; Margaret S Cooper; Levente Meszaros; Guy J Clarkson; Philip J Blower; Peter J Sadler
Journal:  Angew Chem Int Ed Engl       Date:  2016-12-21       Impact factor: 15.336

7.  Photochemical Resolution of a Thermally Inert Cyclometalated Ru(phbpy)(N-N)(Sulfoxide)+ Complex.

Authors:  Lucien N Lameijer; Corjan van de Griend; Samantha L Hopkins; Anne-Geert Volbeda; Sven H C Askes; Maxime A Siegler; Sylvestre Bonnet
Journal:  J Am Chem Soc       Date:  2018-12-26       Impact factor: 15.419

8.  Selective Preparation of a Heteroleptic Cyclometallated Ruthenium Complex Capable of Undergoing Photosubstitution of a Bidentate Ligand.

Authors:  Jordi-Amat Cuello-Garibo; Catriona C James; Maxime A Siegler; Samantha L Hopkins; Sylvestre Bonnet
Journal:  Chemistry       Date:  2018-12-18       Impact factor: 5.236

9.  Internal and External Influences on Stability and Ligand Exchange Reactions in Bromido[3-ethyl-4-aryl-5-(2-methoxypyridin-5-yl)-1-propyl-1,3-dihydro-2H-imidazol-2-ylidene]gold(I) Complexes.

Authors:  Sina Katharina Goetzfried; Sophie Marie Charlotte Koenig; Caroline Marie Gallati; Ronald Gust
Journal:  Inorg Chem       Date:  2021-06-07       Impact factor: 5.165

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.